Claims
- 1. A method to determine the presence or absence of a common hereditary hemochromatosis (HH) gene mutation in an individual, comprising:assessing DNA or RNA from an individual for the presence or absence of HH-associated allele A of a base-pair mutation designated herein 24d1, wherein, as a result, the absence of the allele indicates the likely absence of the HH gene mutation in the genome of the individual and the presence of the allele indicates the likely presence of the HH gene mutation in the genome of the individual.
- 2. The method of claim 1, further comprising assessing the DNA or RNA from the individual for the presence or absence of HH-associated allele G of a base-pair mutation designated herein 24d2, wherein, as a result, the absence of both alleles indicates the likely absence of the HH gene mutation in the genome of the individual and the presence of one or both alleles the likely presence of the HH gene mutation in the genome of the individual.
- 3. The method of claim 1, wherein the assessing step is performed by a process which comprises subjecting the DNA or RNA to amplification using oligonucleotide primers flanking the base-pair mutation 24d1(A).
- 4. The method of claim 3, wherein the assessing step further comprises an oligonucleotide ligation assay.
- 5. The method of claim 4, wherein the assessing step further comprises providing a housing having a first well that is adapted for conducting an oligonucleotide ligation assay and providing a signal when 24d1A is present in the DNA or RNA and a second well that is adapted for conducting an oligonucleotide ligation assay and providing a signal when 24d1G is present in the DNA or RNA.
- 6. The method of claim 5, wherein the assessing step further comprises determining whether the individual is homozygous or heterozygous for 24d1A, wherein when the individual is heterozygous for 24d1A a signal will be observed in both the first and second wells upon conducting the oligonucleotide ligation assay and when the individual is homozygous for 24d1A a signal will be observed in the first well upon conducting the oligonucleotide ligation assay.
- 7. The method of claim 3, wherein the DNA is amplified with oligonucleotide primers of SEQ ID NO:13 and SEQ ID NO:14.
- 8. The method of claim 7, wherein the assessing step further comprises an oligonucleotide ligation assay.
- 9. The method of claim 8, wherein the oligonucleotide ligation assay is accomplished using oligonucleotides of SEQ ID NO:15, SEQ ID NO:16 and SEQ ID NO:17.
- 10. The method of claim 3, wherein RNA is amplified with oligonucleotide primers of SEQ ID NO:18 and SEQ ID NO:19.
- 11. The method of claim 10, wherein the assessing step further comprises an oligonucleotide ligation assay.
- 12. The method of claim 11, wherein the oligonucleotide ligation assay is accomplished using oligonucleotides of SEQ ID NO:15, SEQ ID NO:16, and SEQ ID NO:17.
- 13. The method of claim 2, wherein the assessing step is performed by a process which comprises subjecting the DNA or RNA to amplification using oligonucleotide primers flanking 24d2(G).
- 14. The method of claim 13, wherein the assessing step further comprises an oligonucleotide ligation assay.
- 15. The method of claim 14, wherein the assessing step further comprises providing a housing having a first well that is adapted for conducting an oligonucleotide ligation assay and providing a signal when 24d2G is present in the DNA or RNA and a second well that is adapted for conducting an oligonucleotide ligation assay and providing a signal when 24d2C is present in the DNA or RNA.
- 16. The method of claim 15, wherein the assessing step further comprises detecting whether the DNA or RNA is homozygous or heterozygous for 24d2G, wherein when the DNA or RNA is heterozygous for 24d2G a signal will be observed in both the first and second wells upon conducting the oligonucleotide ligation assay and when the DNA or RNA is homozygous for 24d2G a signal will be observed in the first well upon conducting the oligonucleotide ligation assay.
- 17. The method of claim 13, wherein DNA is amplified with oligonucleotide primers of SEQ ID NO:24 and SEQ ID NO:25.
- 18. The method of claim 17, wherein the assessing step further comprises an oligonucleotide ligation assay.
- 19. The method of claim 18, wherein the oligonucleotide ligation assay is accomplished using oligonucleotides of SEQ ID NO:26, SEQ ID NO:27 and SEQ ID NO:28.
Parent Case Info
This Application is a continuation of U.S. Ser. No. 08/652,265, filed May 23, 1996 (now issued as U.S. Pat. No. 6,025,130), which is a continuation-in part of U.S. Ser. No. 08/632,673, filed Apr. 16, 1996 (now issued as U.S. Pat. No. 5,712,098), which is a continuation-in part of U.S. Ser. No. 08/630,912, filed Apr. 4, 1996 (now abandoned).
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
6025130 |
Thomas et al. |
Feb 2000 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
08/652265 |
May 1996 |
US |
Child |
09/503444 |
|
US |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
08/632673 |
Apr 1996 |
US |
Child |
08/652265 |
|
US |
Parent |
08/630912 |
Apr 1996 |
US |
Child |
08/632673 |
|
US |